Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.22%21.91M | -6.29%89.69M | -1.93%21.04M | 1.69%21.39M | -17.02%26.82M | -2.22%20.44M | 8.12%95.71M | -4.93%21.45M | -5.13%21.03M | 45.75%32.32M |
| Cost of revenue | 32.88%7.22M | -12.26%29.23M | 0.54%6.32M | 13.18%6.53M | -30.86%10.94M | 0.09%5.43M | 33.59%33.31M | -3.32%6.28M | -10.11%5.77M | 149.52%15.83M |
| Gross profit | -2.07%14.69M | -3.11%60.46M | -2.95%14.72M | -2.65%14.86M | -3.75%15.88M | -3.02%15.01M | -1.86%62.4M | -5.58%15.17M | -3.10%15.26M | 4.18%16.5M |
| Operating expense | 45.10%1.91M | 137.18%1.67M | 7.44%-3.58M | 202.57%2.12M | 1.73%1.82M | 479.54%1.32M | -173.80%-4.49M | -435.65%-3.87M | -217.95%-2.06M | 20.32%1.79M |
| Selling and administrative expenses | 13.45%2.45M | 18.38%10.03M | 34.02%2.71M | 0.18%2.81M | 23.43%2.36M | 23.98%2.16M | 30.02%8.48M | 61.10%2.03M | 43.43%2.8M | 25.94%1.91M |
| -General and administrative expense | 13.45%2.45M | 18.38%10.03M | 34.02%2.71M | 0.18%2.81M | 23.43%2.36M | 23.98%2.16M | 30.02%8.48M | 61.10%2.03M | 43.43%2.8M | 25.94%1.91M |
| Total other operating income | -36.23%535K | -35.50%8.36M | 6.80%6.3M | -85.76%693K | 346.67%536K | -59.78%839K | 2,901.85%12.97M | 5,568.27%5.9M | 2,262.62%4.87M | 313.79%120K |
| Operating profit | -6.61%12.78M | -12.11%58.79M | -3.86%18.3M | -26.46%12.74M | -4.41%14.06M | -13.48%13.69M | 16.34%66.89M | 27.67%19.04M | 23.74%17.32M | 2.51%14.71M |
| Net non-operating interest income (expenses) | 38.14%-2.99M | 28.46%-15.91M | 34.72%-3.29M | 34.70%-3.48M | 24.73%-4.31M | 21.38%-4.83M | 10.29%-22.24M | 16.80%-5.04M | 14.35%-5.33M | 8.97%-5.73M |
| Non-operating interest expense | -38.14%2.99M | -28.46%15.91M | -34.72%3.29M | -34.70%3.48M | -24.73%4.31M | -21.38%4.83M | -10.29%22.24M | -16.80%5.04M | -14.35%5.33M | -8.97%5.73M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 20.00%36K | 6K | 0 | 0 | 30K | -71.43%30K | 0 | 175.86%22K | -70.37%8K |
| Less:Write off | --0 | -20.00%-36K | ---6K | --0 | --0 | ---30K | 71.43%-30K | --0 | -175.86%-22K | 70.37%-8K |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 10.20%9.8M | -3.95%42.92M | 7.28%15.02M | -22.94%9.26M | 8.44%9.75M | -8.15%8.89M | 36.17%44.69M | 57.06%14M | 55.09%12.02M | 11.19%8.99M |
| Income tax | 15.82%2.58M | 12.83%9.62M | 13.82%2.53M | 16.85%2.53M | 10.96%2.33M | 9.42%2.23M | 82.74%8.53M | 236.59%2.22M | 4.44%2.17M | 1.55%2.1M |
| Net income | 8.32%7.21M | -7.91%33.3M | 6.05%12.49M | -31.69%6.73M | 7.68%7.42M | -12.84%6.66M | 28.45%36.16M | 11.76%11.78M | 73.61%9.85M | 14.50%6.89M |
| Net income continuous operations | 8.32%7.21M | -7.91%33.3M | 6.05%12.49M | -31.69%6.73M | 7.68%7.42M | -12.84%6.66M | 28.45%36.16M | 11.76%11.78M | 73.61%9.85M | 14.50%6.89M |
| Noncontrolling interests | 18.25%3.12M | 13.41%11.44M | 12.89%2.99M | 19.79%3.03M | 11.83%2.78M | 8.95%2.64M | -7.25%10.09M | -25.34%2.65M | 5.72%2.53M | 2.18%2.49M |
| Net income attributable to the company | 1.79%4.09M | -16.16%21.86M | 4.07%9.51M | -49.49%3.7M | 5.33%4.64M | -22.97%4.02M | 50.92%26.08M | 30.56%9.14M | 123.18%7.32M | 22.86%4.41M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1.79%4.09M | -16.16%21.86M | 4.07%9.51M | -49.49%3.7M | 5.33%4.64M | -22.97%4.02M | 50.92%26.08M | 30.56%9.14M | 123.18%7.32M | 22.86%4.41M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.00%0.0059 | -37.45%0.0314 | -21.39%0.0136 | -62.41%0.0053 | -21.18%0.0067 | -42.16%0.0059 | 47.65%0.0502 | 25.36%0.0173 | 120.31%0.0141 | 19.72%0.0085 |
| Diluted earnings per share | 1.72%0.0059 | -31.89%0.0314 | -14.47%0.0136 | -62.41%0.0053 | -21.18%0.0067 | -34.83%0.0058 | 43.61%0.0461 | 16.19%0.0159 | 120.31%0.0141 | 19.72%0.0085 |
| Dividend per share | 0.02 | |||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.